Showing results (391-400 of 469) with videos related to
Sort By:
Pageof 47
Science Signaling|May 19, 2011
Network-based tools for the identification of novel drug targetsIllés J Farkas, Tamás Korcsmáros, István A Kovács, et al.Rehabilitation Psychology|February 15, 2024
Nutrition and eating beliefs and behaviors among individuals with spinal cord injuries and disorders: Healthy or misconceived?Sherri L LaVela, Justina Wu, Andrea L Nevedal, et al.Spinal Cord|May 19, 2026
Development and content validity of a nutrition knowledge questionnaire for individuals living with spinal cord injuries and disordersRena M Steiger-Chadwick, Gary J Farkas, Lorena Reyes, et al.The Journal of Biological Chemistry|June 28, 1996
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementiaS M Fine, R A Angel, S W Perry, et al.Cancer Research|May 15, 1989
Local distribution and concentration of intravenously injected 131I-9.2.27 monoclonal antibody in human malignant melanomaS Del Vecchio, J C Reynolds, J A Carrasquillo, et al.AJNR. American Journal of Neuroradiology|February 13, 2001
Silent thromboembolic events associated with the treatment of unruptured cerebral aneurysms by use of Guglielmi detachable coils: prospective study applying diffusion-weighted imagingG Rordorf, R J Bellon, R E Budzik, et al.The Journal of Clinical Investigation|June 1, 1985
Characterization of high density lipoprotein binding to human adipocyte plasma membranesB S Fong, P O Rodrigues, A M Salter, et al.Journal of Visualized Experiments : Jove|June 27, 2022
Thermochemical Studies of Ni(II) and Zn(II) Ternary Complexes using Ion Mobility-Mass SpectrometryAnna J Corrales, Anna V Arredondo, Amber A Flores, et al.BMC Systems Biology|January 22, 2013
SignaLink 2 - a signaling pathway resource with multi-layered regulatory networksDávid Fazekas, Mihály Koltai, Dénes Türei, et al.Contraception|July 1, 1990
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mgJ C Wiemeyer, C L Sagasta, J M Roncales Mateo, et al.Pageof 47